Phase II trial adriamycin and cis-dichlorodiammineplatinum(II) in squamous cell, ovarian, and testicular carcinomas

MeSH terms

• Carcinoma, Squamous Cell / drug therapy*
• Cisplatin / administration & dosage
• Cisplatin / adverse effects
• Cisplatin / therapeutic use*
• Clinical Trials as Topic
• Doxorubicin / administration & dosage
• Doxorubicin / adverse effects
• Doxorubicin / therapeutic use*
• Drug Evaluation
• Drug Therapy, Combination
• Female
• Humans
• Male
• Ovarian Neoplasms / drug therapy*
• Testicular Neoplasms / drug therapy*